Certified by Founder Lodge
Ten63 Therapeutics
United States - Durham, North Carolina
START UP
1 Disclosed Funding Rounds $5,190,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Ten63 Therapeutics is focused on improving human health by developing better, more durable therapeutics against cancer and some of the world’s most lethal diseases. We are leveraging our prop
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| June, 16 ,2023 | Series A | $5,190,000 |
SOSV
Hatteras Venture Partners
Draper Associates
Morpheus Ventures
Sigma Group
Truemeds India
Receptor Life Sciences, Inc.
Koneksa
MAYD: MEDS AT YOUR DOORSTEP
Fullife Healthcare Pvt. Ltd.
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
